Ajay Chaudhuri

Research activity per year

Fingerprint

Dive into the research topics where Ajay Chaudhuri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

14 Active
17 Finished

A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants with Metabolic Dysfunction-Associated Steatotic Liver Disease who are at Increased Risk of Developing Major Adverse...
Chaudhuri, A. (PI)
Lilly USA LLC
04/9/26 → 10/12/27
Project: Research
A Phase 3, Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of RO7795074 Over 26 Weeks in Overweight and Obese Participants with Type 1 Diabetes Mellitus
Chaudhuri, A. (PI)
Syneos Health LLC
02/15/26 → 10/30/26
Project: Research
A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Patients With Graves' Disease
Chaudhuri, A. (PI)
Pharmaceutical Research Associates Incorporated
11/12/25 → 06/1/27
Project: Research
A 26-week Study Comparing the Efficacy and Safety of Once-weekly Insulin Icodec and Once-daily Insulin Glargine U100, Both in Combination with Insulin Aspart, in Adults with Type 1 Diabetes
Chaudhuri, A. (PI)
Novo Nordisk Incorporated
07/22/25 → 12/31/26
Project: Research
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating The Safety and Efficacy of Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) / Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Chaudhuri, A. (PI)
Akero Therapeutics Incorporated
04/29/25 → 11/30/29
Project: Research

76 Article
26 Review article
13 Comment/debate
11 Letter
More

Combination of Glucagon-like Peptide-1 Receptor Agonists and Sodium–Glucose Cotransporter Inhibitors in Type 1 Diabetes: Why, when and How? An Exploration of the Rationale and Clinical Scenarios for Combining These 2 Adjunctive Agents
Ghanim, H., Srungavarapu, S. R., Dandona, P. & Chaudhuri, A., 2026, (Accepted/In press) In: Endocrinology and Metabolism Clinics of North America.
Research output: Contribution to journal › Review article › peer-review
Use of glucagon-like peptide-1 receptor agonists in people with history of acute pancreatitis: TriNetX analysis
Nassar, M., Abosheaishaa, H., Misra, A., Dandona, P., Ghanim, H. & Chaudhuri, A., Mar 2025, In: Diabetes and Metabolism. 51, 2, 101613.
Research output: Contribution to journal › Article › peer-review
4 Scopus citations
Evaluating the effectiveness of combined T4 and T3 therapy or desiccated thyroid versus T4 monotherapy in hypothyroidism: a systematic review and meta-analysis
Nassar, M., Hassan, A., Ramadan, S., Desouki, M. T., Hassan, M. A. & Chaudhuri, A., Dec 2024, In: BMC Endocrine Disorders. 24, 1, 90.
Research output: Contribution to journal › Review article › peer-review

Open Access
10 Scopus citations
The authors reply
Dandona, P., Chaudhuri, A. & Ghanim, H., Jan 18 2024, In: New England Journal of Medicine. 390, 3, p. 292 1 p.
Research output: Contribution to journal › Letter › peer-review

Open Access
Semaglutide in Early Type 1 Diabetes
Dandona, P., Chaudhuri, A. & Ghanim, H., 2023, In: New England Journal of Medicine. 389, 10, p. 958-959 2 p.
Research output: Contribution to journal › Letter › peer-review
56 Scopus citations

Ajay Chaudhuri

Personal profile

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants with Metabolic Dysfunction-Associated Steatotic Liver Disease who are at Increased Risk of Developing Major Adverse...

A Phase 3, Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of RO7795074 Over 26 Weeks in Overweight and Obese Participants with Type 1 Diabetes Mellitus

A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Patients With Graves' Disease

A 26-week Study Comparing the Efficacy and Safety of Once-weekly Insulin Icodec and Once-daily Insulin Glargine U100, Both in Combination with Insulin Aspart, in Adults with Type 1 Diabetes

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating The Safety and Efficacy of Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH) / Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Combination of Glucagon-like Peptide-1 Receptor Agonists and Sodium–Glucose Cotransporter Inhibitors in Type 1 Diabetes: Why, when and How? An Exploration of the Rationale and Clinical Scenarios for Combining These 2 Adjunctive Agents

Use of glucagon-like peptide-1 receptor agonists in people with history of acute pancreatitis: TriNetX analysis

Evaluating the effectiveness of combined T4 and T3 therapy or desiccated thyroid versus T4 monotherapy in hypothyroidism: a systematic review and meta-analysis

The authors reply

Semaglutide in Early Type 1 Diabetes

Ajay Chaudhuri

Personal profile

Fingerprint

Collaborations and top research areas from the last five years

Grants & Projects

Research output